Health Care & Life Sciences » Biotechnology | Prothena Corp. PLC

Prothena Corp. PLC

Prothena Corp. PLC
Stock Exchange NASDAQ Stock Market
EPS
$3.2
Market Cap
$403.83 M
Shares Outstanding
39.87 M
Public Float
39.89 M

Profile

Address
77 Sir John Rogersons Quay
Dun Laoghaire Dublin 2
Ireland
Employees -
Website http://www.prothena.com
Updated 07/08/2019
Prothena Corp. Plc is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. The company was founded on December 20, 2012 and is headquartered in Dun Laoghaire, Ireland.

Financials

View All

Gene G. Kinney
President, Chief Executive Officer & Director
Lars G. Ekman
Chairman